BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37244935)

  • 21. Transcription-associated histone pruning demarcates macroH2A chromatin domains.
    Sun Z; Filipescu D; Andrade J; Gaspar-Maia A; Ueberheide B; Bernstein E
    Nat Struct Mol Biol; 2018 Oct; 25(10):958-970. PubMed ID: 30291361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
    Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
    J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astrocyte Elevated Gene-1 Regulates β-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal.
    Hu B; Emdad L; Kegelman TP; Shen XN; Das SK; Sarkar D; Fisher PB
    Mol Cancer Res; 2017 Feb; 15(2):225-233. PubMed ID: 27903708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling.
    Gimple RC; Kidwell RL; Kim LJY; Sun T; Gromovsky AD; Wu Q; Wolf M; Lv D; Bhargava S; Jiang L; Prager BC; Wang X; Ye Q; Zhu Z; Zhang G; Dong Z; Zhao L; Lee D; Bi J; Sloan AE; Mischel PS; Brown JM; Cang H; Huan T; Mack SC; Xie Q; Rich JN
    Cancer Discov; 2019 Sep; 9(9):1248-1267. PubMed ID: 31201181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma.
    Costa BM; Smith JS; Chen Y; Chen J; Phillips HS; Aldape KD; Zardo G; Nigro J; James CD; Fridlyand J; Reis RM; Costello JF
    Cancer Res; 2010 Jan; 70(2):453-62. PubMed ID: 20068170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
    Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
    Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Noncoding RNA
    Chen X; Xie R; Gu P; Huang M; Han J; Dong W; Xie W; Wang B; He W; Zhong G; Chen Z; Huang J; Lin T
    Clin Cancer Res; 2019 Feb; 25(4):1389-1403. PubMed ID: 30397178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
    Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
    Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
    Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.
    Dong F; Li Q; Yang C; Huo D; Wang X; Ai C; Kong Y; Sun X; Wang W; Zhou Y; Liu X; Li W; Gao W; Liu W; Kang C; Wu X
    Nat Commun; 2018 Oct; 9(1):4552. PubMed ID: 30382083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma.
    Voon HPJ; Udugama M; Lin W; Hii L; Law RHP; Steer DL; Das PP; Mann JR; Wong LH
    Nat Commun; 2018 Aug; 9(1):3142. PubMed ID: 30087349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma.
    Johnston MJ; Nikolic A; Ninkovic N; Guilhamon P; Cavalli FMG; Seaman S; Zemp FJ; Lee J; Abdelkareem A; Ellestad K; Murison A; Kushida MM; Coutinho FJ; Ma Y; Mungall AJ; Moore R; Marra MA; Taylor MD; Dirks PB; Pugh TJ; Morrissy S; St Croix B; Mahoney DJ; Lupien M; Gallo M
    Genome Res; 2019 Aug; 29(8):1211-1222. PubMed ID: 31249064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
    Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
    Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.
    Alvarado AG; Turaga SM; Sathyan P; Mulkearns-Hubert EE; Otvos B; Silver DJ; Hale JS; Flavahan WA; Zinn PO; Sinyuk M; Li M; Guda MR; Velpula KK; Tsung AJ; Nakano I; Vogelbaum MA; Majumder S; Rich JN; Lathia JD
    Neuro Oncol; 2016 May; 18(5):656-66. PubMed ID: 26374689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance.
    Huang H; Zhang S; Li Y; Liu Z; Mi L; Cai Y; Wang X; Chen L; Ran H; Xiao D; Li F; Wu J; Li T; Han Q; Chen L; Pan X; Li H; Li T; He K; Li A; Zhang X; Zhou T; Xia Q; Man J
    Nat Commun; 2021 Jun; 12(1):3720. PubMed ID: 34140524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic activity of SOX1 in glioblastoma.
    Garcia I; Aldaregia J; Marjanovic Vicentic J; Aldaz P; Moreno-Cugnon L; Torres-Bayona S; Carrasco-Garcia E; Garros-Regulez L; Egaña L; Rubio A; Pollard S; Stevanovic M; Sampron N; Matheu A
    Sci Rep; 2017 Apr; 7():46575. PubMed ID: 28425506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development.
    Maleszewska M; Kaminska B
    Future Oncol; 2015 Sep; 11(18):2587-601. PubMed ID: 26289459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.